Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-12-12)Premium Content

Seattle Genetics (SGEN)

2014-12-19@12:22:42 ET
Seattle Genetics (SGEN) Trading Near $31.81 Support Level (FBM)

2014-12-19@07:18:00 ET
Form 4: Update Filing for Seattle Genetics Inc (SGEN) (VKR)

2014-12-19@07:17:50 ET
Form 4: Update Filing for Seattle Genetics Inc (SGEN) (VKR)

2014-12-18@13:37:52 ET
Seattle Genetics Bullish Moving Average Crossover Alert (SGEN) (F78)

2014-12-18@13:28:07 ET
Seattle Genetics Makes a Move: Up 4.0% (F77)

2014-12-18@09:00:53 ET
Seattle Genetics Initiates Phase 1b Trial of SGN-CD33A in Combination with Frontline Standard of Care and as Consolidation Therapy for Acute Myeloid Leukemia (BIZ)

2014-12-18@08:12:03 ET
Short-term Underperformance Detected in Shares of AMAG Pharmaceuticals in the Biotechnology Industry (AMAG, ACOR, SGEN, VRTX, LGND) (F70)

2014-12-17@12:19:44 ET
Seattle Genetics (SGEN) Trading Near $34.17 Resistance Level (FBM)

2014-12-17@04:09:13 ET
Seattle and Takeda announce favorable data from Phase III lymphoma trial (DTM)

2014-12-17@04:09:01 ET
Seattle announces encouraging data from Phase I B-cell malignancies trials (DTM)

2014-12-16@16:26:19 ET
Shares of Seattle Genetics Fall to a New 52-Week Low (F71)

2014-12-16@15:04:10 ET
Shares of Seattle Genetics Are Moving Higher on 1.4x Above-Average Volume (SGEN) (F82)

2014-12-16@13:19:52 ET
Seattle Genetics (SGEN) Showing Bearish Technicals (FBM)

2014-12-15@11:57:30 ET
Seattle Genetics Makes a Move: Down 2.3% (F77)

2014-12-12@08:21:04 ET
Potential Seattle Genetics (SGEN) Trade Has 9.19% Downside Protection (FBM)